NCAPG2 and metastatic malignant neoplasm in the lymph nodes: Further multiple regression analysis showed that EIF2S3, NCAPG2, lymph node metastasis, and the pathological stage (II, III, IV) interacted and were risk factors for the prognosis of LUAD (p < 0.05) (Table 1), suggesting that EIF2S3, NCAPG2 might potentially be associated with the pathological stage and lymph node metastasis.